FIELD: medicine.
SUBSTANCE: method for treating postpartum depression in a person in need thereof includes administration of allopregnanolone in a dosing regimen for a period of 60 hours, wherein the dosing regimen includes continuous infusion: 30 mcg/kg/hour of allopregnanolone, starting from hour 0 to hour 4; 60 mcg/kg/hour of allopregnanolone, starting from hour 4 to hour 24; 90 mcg/kg/hour of allopregnanolone, starting from hour 24 to hour 52; 60 mcg/kg/hour of allopregnanolone, starting from hour 24 to hour 52; from hour 52 to hour 56; and 30 mcg/kg/hour of allopregnanolone, starting from hour 56 to hour 60.
EFFECT: invention ensures effective treatment of postpartum depression.
10 cl, 12 dwg, 20 tbl, 6 ex
Title | Year | Author | Number |
---|---|---|---|
NEUROACTIVE STEROIDS, COMPOSITIONS AND METHODS OF USING THEM | 2015 |
|
RU2731000C2 |
NEUROACTIVE STEROID SOLUTIONS AND METHODS FOR ADMINISTRATION | 2016 |
|
RU2803464C2 |
METHODS OF TREATMENT OF EPILEPSY OR STATUS EPILEPTICUS | 2013 |
|
RU2667010C2 |
NEUROACTIVE STEROID FORMULATIONS AND METHODS OF TREATING CNS DISORDERS | 2013 |
|
RU2681835C2 |
ANAESTHETIC COMPOSITION | 2011 |
|
RU2574022C2 |
CB1 RECEPTOR ANTAGONISTS | 2012 |
|
RU2593751C2 |
HUMANISED ANTI-TAU ANTIBODIES | 2015 |
|
RU2743152C2 |
METHODS OF TREATING ALLERGIC DISEASES | 2011 |
|
RU2587061C2 |
ORGANIC COMPOUNDS | 2019 |
|
RU2809023C2 |
NEUROACTIVE STEROIDS SUBSTITUTED AT POSITION 10 WITH A CYCLIC GROUP FOR USE IN THE TREATMENT OF CNS DISORDERS | 2019 |
|
RU2796006C2 |
Authors
Dates
2022-02-08—Published
2017-03-08—Filed